Search Results - "Cystadenocarcinoma"

  • Showing 1 - 7 results of 7
Refine Results
  1. 1

    The long-term survival in primary retroperitoneal mucinous cystadenocarcinoma: a case report by Hirotaka Tokai, Yasuhiro Nagata, Ken Taniguchi, Naomi Matsumura, Amane Kitasato, Takayuki Tokunaga, Hiroaki Takeshita, Tamotsu Kuroki, Shigeto Maeda, Masahiro Ito, Hikaru Fujioka

    Published 2017-11-01

    Abstract Background Primary retroperitoneal mucinous cystadenocarcinoma (PRMC) is extremely rare, and its biological behavior, pathogenesis, optimum treatments, and prognosis remain to be elucidated. We herein report a case of PRMC with an 80-month follow-up. Case presentation A 29-year-old woman wa...

    Full description

    Subjects: Get full text
    Article
  2. 2

    Usefulness of 18F-fluorodeoxyglucose-positron emission tomography/computed tomography in primary cystadenocarcinoma of the mesentery: a case report by Yuto Hozaka, Yuko Mataki, Hiroshi Kurahara, Kiyonori Tanoue, Tetsuya Idichi, Yota Kawasaki, Satoshi Iino, Pramod Nepal, Takaaki Arigami, Kosei Maemura, Hirotsugu Noguchi, Hiroyuki Shinchi, Akihide Tanimoto, Shoji Natsugoe, Takao Ohtsuka

    Published 2020-12-01

    Abstract Background Mesenteric cysts have various histological forms, including mesenteric cystadenomas and borderline cystic neoplasms. Primary cystadenocarcinoma of the mesentery is extremely rare; therefore, the clinical and radiological features of this tumor have not been fully elucidated. Case...

    Full description

    Subjects: Get full text
    Article
  3. 3

    Remote results of pathogenetic therapy of cystic breast disease by G. Kh. Khanafiev, S. A. Berzin, S. M. Demidov

    Published 2015-01-01

    With 2000 year of pathogenetic treatment of fibrocystic breast disease preventing cystadenocarcinoma has led to positive results. In 2000–2001 years the percentage devoted to oncological indications for surgical treatment of patients with fibrocystic disease of the breast, was less than 3 % of the t...

    Full description

    Subjects: Get full text
    Article
  4. 4

    A long-term survivor of metachronous liver metastases of pancreatic serous cystic neoplasm associated with von Hippel–Lindau disease by Takashi Kokumai, Masamichi Mizuma, Katsuya Hirose, Hideaki Karasawa, Masaharu Ishida, Hideo Ohtsuka, Kei Nakagawa, Takanori Morikawa, Takashi Kamei, Atsushi Masamune, Toru Furukawa, Michiaki Unno

    Published 2021-06-01

    Abstract Background Pancreatic serous cystic neoplasm (SCN) is an uncommon exocrine neoplasm, which is believed to be a benign entity. However, some of these neoplasms may occasionally attain metastatic ability. Von Hippel–Lindau disease (VHL) manifests a dominantly inherited systemic syndrome accom...

    Full description

    Subjects: “…Serous cystadenocarcinoma…”
    Get full text
    Article
  5. 5

    Diagnostic and Treatment Errors in Biliary Cystadenomas and Cystadenocarcinomas: Clinical Cases by Kh. A. Ayvazyan, E. D. Kuzminikh, T. V. Shevchenko, Yu. A. Stepanova, O. I. Zhavoronkova, D. A. Ionkin, V. S. Shirokov, A. V. Glotov, B. N. Gurmikov, A. V. Zhao

    Published 2022-12-01

    Background. Biliary cystadenomas and cystadenocarcinomas are rare cystic tumors of the liver. Complicated differential diagnostics for simple cysts often leads to errors in surveillance of patients with these tumors. Cystadenoma and cystadenocarcinoma should be suspected upon detection of single or...

    Full description

    Subjects: Get full text
    Article
  6. 6

    Role of Tumor Microenvironment in the Risk of Thromboembolic Complications in Ovarian Cancer by A. S. Safonov, M. V. Zabelin, A. R. Uldashbaeva, L. I. Bashirova, R. O. Venidictov

    Published 2024-10-01

    Introduction. Incidence of ovarian cancer remains high in the overall prevalence of oncological pathology. Adjuvant chemotherapy refers to its treatment options. Patients with oncological pathology are faced with a high risk of thrombosis and thromboembolism, with up to 30% lethal outcome within a m...

    Full description

    Subjects: Get full text
    Article
  7. 7

    CHEMILUMINESCENCE INTENSITY, ANTIOXIDANT SYSTEM STATE AND OXIDATIVE MODIFICATION OF PROTEINS IN BLOOD IN OVARIAN CANCER PATIENTS WITH A LOCAL RECURRENT TUMOR by I. A. Goroshinskaya, G. A. Nerodo, E. I. Surikova, P. S. Surikova, V. V. Vnukov, E. V. Shalashnaja, I. V. Neskubina, L. A. Nemashkalova, N. A. Maximova, M. M. Sergeeva

    Published 2016-02-01

    The state of antioxidant system (the activity of catalase and ceruloplasmine), the intensity of chemiluminescence, and oxidative modification of proteins were studied in blood plasma of 61 patients with ovarian cancer (cystadenocarcinoma) III–IV stage in state of remission and ones with a local recu...

    Full description

    Subjects: “…and oxidative modification of proteins were studied in blood plasma of 61 patients with ovarian cancer (cystadenocarcinoma) iii–iv stage in state of remission and ones with a local recurrent tumor. the dynamics of these indices was analyzed in dependence of recurrent tumor vascularization. the statistically significant changes of the activity of some links of antioxidant system were found…”
    Get full text
    Article